The article discusses Amgen Inc. as a blue chip dividend stock. Amgen's financial health, acquisitions, dividend growth, and potential drug developments are highlighted. The company's performance, dividend yield, and shareholder rewards are analyzed.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing